Sulfatase 2 (SULF2)—an enzyme often overexpressed in HCC—removes 6-O-sulfate groups from HSGAG, disrupting this complex, releasing Wnt, and leading to enhanced Wnt signaling activity (68). This evidence concerns the gene SULF2 and hepatocellular carcinoma.